novo nordisk glp-1 drug Ozempic is first FDA-approved for kidney disease Novo's patent expires in India:

2 In separate clinical studies of adults with overweight or obesity, about 1 in 4 taking Wegovy oral semaglutide 25 mg (64 weeks), about 1 in 3 taking Wegovy injection 2.4 mg (68 weeks), and about 1 in 2 taking Wegovy injection 7.2 mg (72 weeks) lost 20% of body weight, alongside diet and exercise

doi: 10.1016/j.molmet.2017.02.002

The stronger goal is to build a supervised plan that helps preserve muscle, reduce metabolic risk, manage side effects, and maintain healthier habits after the most active weight-loss phase slows down

Diet and lifestyle modifications during treatment can dramatically influence outcomes with either Mounjaro or retatrutide

dollars, we converted its reported revenues to dollars at the rate of 1 krone = $0.145, the prevailing exchange rate when we did the analysis

Why Certain Foods Make GLP-1 Nausea Worse When stomach emptying slows down, some foods become harder to tolerate